Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

被引:5
|
作者
Alhudiri, Inas [1 ,2 ]
Nolan, Christopher [1 ]
Ellis, Ian [1 ]
Elzagheid, Adam [2 ]
Green, Andrew [1 ]
Chapman, Caroline [3 ]
机构
[1] Univ Nottingham, Biodiscovery Inst, Fac Med, Nottingham Breast Canc Res Ctr,Breast Pathol Res G, Nottingham, England
[2] Libyan Biotechnol Res Ctr, Genet Engn Dept, Tripoli, Libya
[3] Nottingham Univ Hosp NHS Trust, Eastern Bowel Canc Screening Hub, Nottingham, England
关键词
Breast cancer; Cathepsin D; Immunohistochemistry; Tissue microarray; Prognosis; GROWTH; ACTIVATION; INHIBITOR; ESTROGEN; SURVIVAL; INDEX; RNA;
D O I
10.1007/s10549-024-07293-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. There are conflicting results regarding Cathepsin D significance as prognostic and predictor marker in breast cancer. This study aimed to evaluate the expression and prognostic significance of Cathepsin D in early-stage breast cancer. Methods Expression of Cathepsin D was assessed by immunohistochemical staining of tissue microarrays, in a large well-characterized series of early-stage operable breast cancer (n = 954) from Nottingham Primary Breast Carcinoma Series between the period of 1988 and 1998 who underwent primary surgery. Correlation of Cathepsin D expression with clinicopathological parameters and prognosis was evaluated. Results Cathepsin D expression was positive in 71.2% (679/954) of breast cancer tumours. Positive expression of Cathepsin D was significantly associated with high histological grade (p = 0.007), pleomorphism (p = 0.002), poor Nottingham Prognostic Index (NPI) score (p < 0.002), recurrence (p = 0.005) and distant metastasis (p < 0.0001). Kaplan-Meier analysis showed that Cathepsin D expression was significantly associated with shorter breast cancer-specific survival (p = 0.001), higher risk of recurrence (p = 0.001) and distant metastasis (p < 0.0001). ER-positive tumours expressing Cathepsin D and treated with tamoxifen demonstrated a significantly higher risk of distant metastasis. Conclusion Cathepsin D expression significantly predicts poor prognosis in breast cancer and is associated with variables of poor prognosis and shorter outcome. The strong association of Cathepsin D with aggressive tumour characteristics and poor outcomes warrants further research of its potential as a therapeutic target The results also suggest a possible interaction between Cathepsin D and tamoxifen therapy in ER-positive breast cancer which needs further investigation to elucidate the underlying mechanisms.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [41] The expression and prognostic value of protein tyrosine kinase 6 in early-stage cervical squamous cell cancer
    XiaoJing Wang
    Ying Xiong
    ZeBiao Ma
    JianChuan Xia
    YanFang Li
    ChineseJournalofCancer, 2016, 35 (07) : 374 - 381
  • [42] Prognostic value of three microRNA expression profiles in early-stage squamous cell lung cancer (SqCLC).
    Skrzypski, M. T.
    Szymanowska, A.
    Jassem, E.
    Czapiewski, P.
    Rzepko, R.
    Biernat, W.
    Pawowski, R.
    Rzyman, W.
    Jassem, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] pCR Score: a novel prognostic method to estimate the predictive probability of pCR in early-stage breast cancer patients
    Peterson, Joseph
    Cole, John A., Jr.
    Berry, Donald A.
    Cook, Daniel
    Howard, Frederick M.
    Nanda, Rita
    Wolf, Clifford
    Gabani, Prashant S.
    Takiar, Vinita
    Kuzmiak, Cherie
    Carey, Lisa
    Fox, Daniel
    Chalasani, Pavani
    Antony, Anuja K.
    CANCER RESEARCH, 2023, 83 (05)
  • [44] PARP expression in early breast cancer and its predictive value for response to neoadjuvant chemotherapy
    Loibl, S.
    Mueller, B.
    Von Minckwitz, G.
    Blohmer, J. U.
    Bois, A. D.
    Huober, J. B.
    Fend, F.
    Budczies, J.
    Denkert, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
    Eivind Valen Egeland
    Kjetil Boye
    Daehoon Park
    Marit Synnestvedt
    Torill Sauer
    Bjørn Naume
    Elin Borgen
    Gunhild M. Mælandsmo
    Breast Cancer Research and Treatment, 2017, 162 : 127 - 137
  • [46] The value of postexcision preradiation mammography in patients with early-stage breast cancer
    Grann, A
    Abdou, JC
    Dragman, N
    Goodman, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 285 - 288
  • [47] Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer
    Egeland, Eivind Valen
    Boye, Kjetil
    Park, Daehoon
    Synnestvedt, Marit
    Sauer, Torill
    Naume, Bjorn
    Borgen, Elin
    Maelandsmo, Gunhild M.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (01) : 127 - 137
  • [48] PROGNOSTIC VALUE OF CATHEPSIN-D EXPRESSION IN BREAST-CANCER - IMMUNOHISTOCHEMICAL ASSESSMENT AND CORRELATION WITH RADIOMETRIC ASSAY
    TAN, PE
    BENZ, CC
    DOLLBAUM, C
    MOORE, DH
    EDGERTON, SM
    ZAVA, DT
    THOR, AD
    ANNALS OF ONCOLOGY, 1994, 5 (04) : 329 - 336
  • [49] Prognostic and Predictive Value of a Breast Cancer Expression Signature in Localized Prostate Cancer
    Abida, Wassim
    Scher, Howard I.
    JAMA ONCOLOGY, 2017, 3 (12) : 1673 - 1674
  • [50] Effect of neoadjuvant chemotherapy on peritumoral edema in early stage breast cancer and its prognostic value
    Shigematsu, Hideo
    Fujimoto, Mutsumi
    Kobayashi, Yoshie
    Yoshiyama, Tomoyuki
    Matsuura, Noriaki
    Komoto, Daisuke
    Kuraoka, Kazuya
    CANCER RESEARCH, 2024, 84 (09)